GS
TTP

Gagnon Securities’s TITAN PHARMACEUTICAL INC TTP Stock Holding History

Gagnon Securities’s Portfolio TTP Stock Details TTP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-35,092
Closed -$116K – 100
2017
Q1 		$116K Sell
35,092
-980
-3% -$3.24K 0.05% 87
2016
Q4 		$144K Sell
36,072
-25,756
-42% -$103K 0.06% 87
2016
Q3 		$364K Buy
+61,828
New +$364K 0.15% 67
2016
Q2 		– Sell
-62,628
Closed -$300K – 101
2016
Q1 		$300K Buy
62,628
+36
+0.1% +$172 0.14% 67
2015
Q4 		$278K Buy
62,592
+1,588
+3% +$7.05K 0.13% 67
2015
Q3 		$243K Sell
61,004
-274,695
-82% -$1.09M 0.12% 67
2015
Q2 		$269K Hold
335,699
– – 0.11% 68
2015
Q1 		$238K Hold
335,699
– – 0.08% 77
2014
Q4 		$155K Sell
335,699
-137,410
-29% -$63.4K 0.05% 85
2014
Q3 		$263K Buy
473,109
+1,250
+0.3% +$695 0.09% 74
2014
Q2 		$370K Sell
471,859
-18,973
-4% -$14.9K 0.12% 64
2014
Q1 		$329K Buy
490,832
+4,115
+0.8% +$2.76K 0.1% 74
2013
Q4 		$294K Hold
486,717
– – 0.09% 74
2013
Q3 		$327K Buy
486,717
+9,030
+2% +$6.07K 0.1% 67
2013
Q2 		$220K Buy
+477,687
New +$220K 0.08% 64

Other funds holding TTP

VIA
Vantage Investment Advisors State College, Pennsylvania $477M AUM 17.38% 1-Year Est. Return

Gagnon Securities's TTP Position: Q2 2017 in Review

Gagnon Securities sold out of TITAN PHARMACEUTICAL INC (TTP) in Q2 2017, closing a stake of 35,092 shares — an estimated $116K sold.

Gagnon Securities first reported a position in TTP in Q2 2013 and held it in 15 quarters. The position peaked at $370K in Q2 2014. 1 fund tracked by Wall St. Rank holds TTP as of Q2 2017.

  • Gagnon Securities reported no remaining TITAN PHARMACEUTICAL INC position as of Q2 2017 after selling out during the quarter.
  • Gagnon Securities sold 35,092 TITAN PHARMACEUTICAL INC shares in Q2 2017, an estimated $116K.
  • Gagnon Securities first reported a position in TITAN PHARMACEUTICAL INC in Q2 2013 and held it in 15 quarters.
  • Gagnon Securities's TITAN PHARMACEUTICAL INC position peaked at $370K in Q2 2014.
  • 1 fund tracked by Wall St. Rank held TITAN PHARMACEUTICAL INC as of Q2 2017.

Based on Gagnon Securities's 13F filing for Q2 2017, filed 20 Jul 2017.